Topics in health care innovation

devon/Bigstock

Article Highlights

  • #Medicine is more than a diagnosis and treatment - patients value more than the outcomes metrics tend to capture

    Tweet This

  • The disconnect between medicine and #SiliconValley is important because technological #innovation is needed in medicine

    Tweet This

  • Most contemporary medicine is generally regarded as a negative good – we use because we have to, not that we want to

    Tweet This

Where’s Silicon Valley when we need it? The inexorable rise of healthcare costs has created not only a crisis waiting to happen, but also an urgent need for innovation – exactly the sort of thing for which Silicon Valley is justly famous. So where is it?

While entrepreneurs in the Valley and elsewhere have achieved remarkable success (at least historically) developing new drugs and devices , more fundamental innovation in healthcare delivery – particularly the sort designed to take costs out of the system — has proved far more elusive.

It’s not for lack of trying. Almost every legendary Silicon Valley entrepreneur (see here; also here) has recognized the opportunity: our healthcare system is legendary for its inefficiencies, complexity, and opacity – all areas that seem utterly amenable to a technology-driven solution. Yet, to date, the results have been middling at best. Why hasn’t there been a Google or a Facebook in the healthcare space?

One reason may be that existing stakeholders are more entrenched than generally appreciated; we may also be more reluctant to tinker with our health than we are to try out the latest app. It’s also likely that at least until recently, entrepreneurs were more incentivized to create expensive solutions than to engineer cost-effective ones (as this
McKinsey report suggests).

David Shaywitz, M.D., is an adjunct scholar at AEI.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

David
Shaywitz
  • Dr. Shaywitz trained in internal medicine and endocrinology at MGH, and conducted his post-doctoral research in the Melton lab at Harvard. He gained experience in early clinical drug development in the Department of Experimental Medicine at Merck, then joined the Boston Consulting Group’s Healthcare and Corporate Development practices, where he focused on strategy and organizational design. He is currently Director of Strategic and Commercial Planning at Theravance, a publicly-held drug development company in South San Francisco.

  • Email: davidshaywitz.aei@gmail.com

What's new on AEI

image How to beat Memorial Day traffic forever
image Bernanke stumbles, markets react
image Don't edit the First Amendment
image Home Economics
AEI on Facebook
Events Calendar
  • 20
    MON
  • 21
    TUE
  • 22
    WED
  • 23
    THU
  • 24
    FRI
Tuesday, May 21, 2013 | 5:00 p.m. – 6:30 p.m.
Free beer: Liberating libations from ‘Bootleggers and Baptists’

Join us for a discussion of the history and future of federal and state alcohol regulation and competition, followed by a reception with beer, wine, and spirits.

Wednesday, May 22, 2013 | 5:00 p.m. – 6:30 p.m.
NCLB sanctions: Tests taken, lessons learned

Join education scholars and practitioners for a discussion about the latest NCLB research and its implications for future education policy.

Thursday, May 23, 2013 | 12:00 p.m. – 1:30 p.m.
Competing visions of the common good: Rethinking help for the poor

What shared commitments do we have as citizens and neighbors to care for one another? How can a proper ordering of America’s political economy enable the most people to have the best life? At this event, Rep. Frank Wolf (R-VA), a longtime champion of human rights causes, and AEI President Arthur Brooks will join Wallis in addressing these and other questions.

Event Registration is Closed
No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.